Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,537
datasets available to search
ShareScore release 0.9.0
Dataset results
8,537 results for “Openness”
A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension
ClinicalTrials.gov study NCT01781962. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
ClinicalTrials.gov study NCT01276353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
ClinicalTrials.gov study NCT02670330. IPD Sharing: Not stated. Countries: 12. Publications: 0.
A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
ClinicalTrials.gov study NCT00000772. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease
ClinicalTrials.gov study NCT03009396. IPD Sharing: NO. Countries: 7. Publications: 0.
An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
ClinicalTrials.gov study NCT03977792. IPD Sharing: Not stated. Countries: 0. Publications: 1.
An Open Label Extension Study of the Efficacy of MORAb-003
ClinicalTrials.gov study NCT01018563. IPD Sharing: Not stated. Countries: 2. Publications: 0.
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
ClinicalTrials.gov study NCT00525824. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds
ClinicalTrials.gov study NCT02803164. IPD Sharing: NO. Countries: 1. Publications: 0.
Stimgenics Open-Label, Post Market Study
ClinicalTrials.gov study NCT03606187. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label of Clinical Trial of Sulforaphane in Children With Autism
ClinicalTrials.gov study NCT02654743. IPD Sharing: NO. Countries: 0. Publications: 1.
An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukem
ClinicalTrials.gov study NCT01498445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
ClinicalTrials.gov study NCT03551821. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis
ClinicalTrials.gov study NCT02518620. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease
ClinicalTrials.gov study NCT00660881. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
ClinicalTrials.gov study NCT06514534. IPD Sharing: YES. Countries: 1. Publications: 0.
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostat
ClinicalTrials.gov study NCT07190300. IPD Sharing: YES. Countries: 5. Publications: 0.
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
ClinicalTrials.gov study NCT00555438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier
ClinicalTrials.gov study NCT01130298. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants
ClinicalTrials.gov study NCT03276052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.